PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE
2026-04-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Miracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer's Patients Using 'SMART M-CELL'-Based CD34+ Cell-Rich Autologous Blood Concentrate Therapy
2026-04-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HanchorBio Selects Bloomberg to Strengthen its Strategic Intelligence Across Drug Development and Global Biopharma
2026-04-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
2026-04-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
CMUH and Partners Unveil Breakthrough Targeted Exosome Platform for Non-Invasive Spinal Cord Injury Repair
2026-04-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Servier completes the acquisition of Day One Biopharmaceuticals
2026-04-23T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fosun Health Strengthens Regional Presence at GlobalHealth Asia-Pacific Forum 2026, Showcasing "China Solution" and Winning Three Major Awards
2026-04-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Travel 
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer
2026-04-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations
2026-04-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
2026-04-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.